Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. (CBIH): 3 pipeline candidates · ~0 mo cash runway. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
0.1 months
D/E -1.00 · 0% dilution
N/A
3 candidates
N/A
N/A
A transparent, data-derived signal for Cannabis Bioscience International Holdings, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$3.5M
Cash
$90
Quarterly Burn
$15K
Runway
0.1 mo
Revenue
$11K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (3 candidates)
Frequently asked questions
How many drug candidates are in Cannabis Bioscience International Holdings, Inc.'s pipeline?
Cannabis Bioscience International Holdings, Inc. (CBIH) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Cannabis Bioscience International Holdings, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Cannabis Bioscience International Holdings, Inc. has approximately 0.1 months of cash runway.
What is Cannabis Bioscience International Holdings, Inc.'s market capitalization?
Cannabis Bioscience International Holdings, Inc.'s market capitalization is approximately $3.5M.
Who is the CEO of Cannabis Bioscience International Holdings, Inc.?
Mr. Dante Picazo is the chief executive officer of Cannabis Bioscience International Holdings, Inc. (CBIH).
Get the full picture on Cannabis Bioscience International Holdings, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.